IBDEI1HD ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26568,1,3,0)
 ;;=3^Primary Cardiomyopathy NEC
 ;;^UTILITY(U,$J,358.3,26568,1,4,0)
 ;;=4^425.4
 ;;^UTILITY(U,$J,358.3,26568,2)
 ;;=^87808
 ;;^UTILITY(U,$J,358.3,26569,0)
 ;;=428.0^^158^1625^7
 ;;^UTILITY(U,$J,358.3,26569,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26569,1,3,0)
 ;;=3^Congestive Heart Failure
 ;;^UTILITY(U,$J,358.3,26569,1,4,0)
 ;;=4^428.0
 ;;^UTILITY(U,$J,358.3,26569,2)
 ;;=^54758
 ;;^UTILITY(U,$J,358.3,26570,0)
 ;;=496.^^158^1625^5
 ;;^UTILITY(U,$J,358.3,26570,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26570,1,3,0)
 ;;=3^Chr Airway Obstruct Nec
 ;;^UTILITY(U,$J,358.3,26570,1,4,0)
 ;;=4^496.
 ;;^UTILITY(U,$J,358.3,26570,2)
 ;;=^24355
 ;;^UTILITY(U,$J,358.3,26571,0)
 ;;=491.21^^158^1625^13
 ;;^UTILITY(U,$J,358.3,26571,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26571,1,3,0)
 ;;=3^Ob Ch Bronchitis W Exacerb
 ;;^UTILITY(U,$J,358.3,26571,1,4,0)
 ;;=4^491.21
 ;;^UTILITY(U,$J,358.3,26571,2)
 ;;=^269954
 ;;^UTILITY(U,$J,358.3,26572,0)
 ;;=493.20^^158^1625^6
 ;;^UTILITY(U,$J,358.3,26572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26572,1,3,0)
 ;;=3^Chr Obs Asthma W/O Stat Asth/A
 ;;^UTILITY(U,$J,358.3,26572,1,4,0)
 ;;=4^493.20
 ;;^UTILITY(U,$J,358.3,26572,2)
 ;;=^269964
 ;;^UTILITY(U,$J,358.3,26573,0)
 ;;=491.20^^158^1625^14
 ;;^UTILITY(U,$J,358.3,26573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26573,1,3,0)
 ;;=3^Ob Ch Bronchitis W/O Exacerb
 ;;^UTILITY(U,$J,358.3,26573,1,4,0)
 ;;=4^491.20
 ;;^UTILITY(U,$J,358.3,26573,2)
 ;;=^269953
 ;;^UTILITY(U,$J,358.3,26574,0)
 ;;=492.8^^158^1625^10
 ;;^UTILITY(U,$J,358.3,26574,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26574,1,3,0)
 ;;=3^Emphysema Nec
 ;;^UTILITY(U,$J,358.3,26574,1,4,0)
 ;;=4^492.8
 ;;^UTILITY(U,$J,358.3,26574,2)
 ;;=^87569
 ;;^UTILITY(U,$J,358.3,26575,0)
 ;;=V17.3^^158^1625^12
 ;;^UTILITY(U,$J,358.3,26575,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26575,1,3,0)
 ;;=3^Fam Hx-Ischem Heart Dis
 ;;^UTILITY(U,$J,358.3,26575,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,26575,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,26576,0)
 ;;=410.92^^158^1625^1
 ;;^UTILITY(U,$J,358.3,26576,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26576,1,3,0)
 ;;=3^AMI NOS, Subsequent
 ;;^UTILITY(U,$J,358.3,26576,1,4,0)
 ;;=4^410.92
 ;;^UTILITY(U,$J,358.3,26576,2)
 ;;=^269675
 ;;^UTILITY(U,$J,358.3,26577,0)
 ;;=412.^^158^1625^15
 ;;^UTILITY(U,$J,358.3,26577,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26577,1,3,0)
 ;;=3^Old Myocardial Infarction
 ;;^UTILITY(U,$J,358.3,26577,1,4,0)
 ;;=4^412.
 ;;^UTILITY(U,$J,358.3,26577,2)
 ;;=^259884
 ;;^UTILITY(U,$J,358.3,26578,0)
 ;;=V45.01^^158^1625^4
 ;;^UTILITY(U,$J,358.3,26578,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26578,1,3,0)
 ;;=3^Cardiac Pacemaker In Situ
 ;;^UTILITY(U,$J,358.3,26578,1,4,0)
 ;;=4^V45.01
 ;;^UTILITY(U,$J,358.3,26578,2)
 ;;=^303419
 ;;^UTILITY(U,$J,358.3,26579,0)
 ;;=519.9^^158^1625^18
 ;;^UTILITY(U,$J,358.3,26579,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26579,1,3,0)
 ;;=3^Resp System Disease Nos
 ;;^UTILITY(U,$J,358.3,26579,1,4,0)
 ;;=4^519.9
 ;;^UTILITY(U,$J,358.3,26579,2)
 ;;=^105137
 ;;^UTILITY(U,$J,358.3,26580,0)
 ;;=V17.49^^158^1625^11
 ;;^UTILITY(U,$J,358.3,26580,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26580,1,3,0)
 ;;=3^Fam Hx-Cardiovas Dis Nec
 ;;^UTILITY(U,$J,358.3,26580,1,4,0)
 ;;=4^V17.49
 ;;^UTILITY(U,$J,358.3,26580,2)
 ;;=^295306
 ;;^UTILITY(U,$J,358.3,26581,0)
 ;;=V45.82^^158^1625^16
 ;;^UTILITY(U,$J,358.3,26581,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26581,1,3,0)
 ;;=3^PTCA Status
 ;;^UTILITY(U,$J,358.3,26581,1,4,0)
 ;;=4^V45.82
